Sandra Brosda

6PUBLICATIONS
59CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 17, 2024
Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.

Jay Gunawardana, Soi C Law, Muhammed B Sabdia

|Jul 07, 2023
C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients.

Vanessa F Bonazzi, Lauren G Aoude, Sandra Brosda

|May 31, 2023
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy.

Marjan M Naeini, Felicity Newell, Lauren G Aoude

|May 13, 2022
Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid-induced DNA damage.

Jeffrey Molendijk, Cathryn M Kolka, Henry Cairns

|Apr 03, 2021
Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients.

Lauren G Aoude, Bernadette Z Y Wong, Vanessa F Bonazzi

Pageof 1